|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer:a randomised,double-blind,phase 3 study显示文摘 | Ciuleanu T Brodowicz T Zielinski C | | 0，，： | 1 |
| 2 | Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study显示文摘 | Ciuleanu T Brodowicz T Zielinski C | 2009 | Lancet2009，374，： | 1 |
| 3 | Monotherapy with docetaxel in second - or third - line treatment of anthracycline - resistant metastatic breast cancer显示文摘 | Brodowicz T Koestler WJ Tomek S | 2000 | Anticancer Drugs2000，11，3： | 1 |
| 4 | Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non small-cell lung cancer:A randomised, double-blind, phase 3 study显示文摘 | Ciuleanu T Brodowicz T Zielinski C | 2009 | Lancet2009，374，9： | 1 |
| 5 | Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer:a randomized,double-blind,phase 3 study显示文摘 | Ciuleanu T Brodowicz T Zielinski C | 2009 | Lancet2009，374，9699： | 1 |
| 6 | Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer:a randomised,double-blind,phase 3 study显示文摘 | Ciuleanu T Brodowicz T Zielinski C | | 0，，9699： | 1 |
| 7 | Cisplatin and gemcitabine first-line chemotherapy followed by maintenance gemcitabine or best supportive care in advanced non-small cell lung cancer: a phase Ⅲ trial显示文摘 | Brodowicz T Krzakowski M Zwitter M | 2006 | Lung Cancer2006，52，2： | 1 |
| 8 | Maintenance pemetrexed plus best supportive care (BSC) versus placebo plus BSC: A phase Ⅲ study显示文摘 | Ciuleanu TE Brodowicz T Belani CP | 2008 | J Clin Oneol2008，，： | 1 |
| 9 | Maintenance pemetrexed plus best supportive care (BSC)versus placebo plus BSC: A phase Ⅲ study显示文摘 | Cluleanu TE Brodowicz T Belani CP | 2008 | J Clin Oncol2008，26，1： | 1 |
| 10 | Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised: double-blind,phase 3 study显示文摘 | Ciuleanu T Brodowicz T Zielinski C | 2009 | Lancet2009，374，9699： | 1 |
| 11 | Maintenan- cepeme-trexed plus bestsupportive care (BSC) versus placebo plusBSC:A phase study显示文摘 | Ciuleanu TE Brodowicz T Belani CP | 2008 | J Clin Oncol2008，26，15： | 1 |
| 12 | Monotherapy with docetaxel in second or third- line treatment of anthracycline risistant metastatic breast cancer显示文摘 | Brodowicz T Kosetler W J | 2000 | Anticancer Drugs2000，11，3： | 1 |
| 13 | Treatment-by-histology interaction analyses in three phase III trials show superiority of pemetrexed in nonsquamous non-small cell lung cancer 显示文摘 | Scagliotti G Brodowicz T Shepherd FA | 2011 | J Tho- rac Oncol2011，6，1： | 1 |
| 14 | Soluble HER-2/neu neutralizes biologic effects of anti-HER-2/neu antibody on breast cancer cells in vitro显示文摘 | Brodowicz T Wiltschke C Budinsky A C | 1997 | Int J Cancer1997，73，6： | 1 |
| 15 | Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer:a randomised,double-blind,phase 3 study显示文摘 | Ciuleanu T Brodowicz T Zielinski C | | 0，，： | 1 |
| 16 | Cisplatin and gemcitabine first-line chemotherapy followed by maintenance gemcitabine or best supportive care in advanced non-small cell lung cancer:A phase Ⅲ trial显示文摘 | Brodowicz T Krzakowski M Zwitter M | | 0，，02： | 1 |
| 17 | Cisplatin and gemcitabine first-line chemotherapy followed by maintenance gemcitabine or best supportive care in advanced non-small cell lung cancer:a phaseⅢtrial显示文摘 | Brodowicz T Krzakowski M Zwitter M | | 0，，： | 1 |
| 18 | Cisplatin and gemcitabine first-line chemotherapy followed by maintenance gemcitabine or best supportive care in advanced non-small cell lung cancer:a phaseⅢtrial显示文摘 | Brodowicz T Krzakowski M Zwitter M | 2006 | Lung Cancer2006，52，2： | 1 |
| 19 | Single-agent gemcitabine as second- and third-line treat in metastatic breast cancer 显示文摘 | Brodowicz T Moslinger R | 2000 | Breast2000，9，6： | 1 |
| 20 | Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non small cell lung cancer: a randomised, double-blind, phase 3 study显示文摘 | Ciuleanu T Brodowicz T Zielinski C | 2009 | Lancet2009，374，9699： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员